…a gentrification of consciousness, a brave new world of psychedelic haves and have-nots… the gentrification of consciousness often involves stripping the journeys to altered states of all their historical, cultural, and religious significance and commodifying them in the mill of mass consumption… “The trauma we’re dealing with most is the trauma that comes from the…
Much as happened with the cannabis industry a decade ago, a culture clash is now developing between social justice activists who fought for the legalisation of psychedelics and [the] wealthy… often new to the drugs, who have the resources to dominate an emerging industry. “The idea that psychedelics should only be used to heal something…
The technocratic model of medicine… mind-body separation allows for us to subconsciously develop the idea that our bodies are property of an institution, and are reliant on medical intervention for survival. The issue of medical misogyny is one that is deeply rooted in technocratic medicine… industrialized medicine is reliant on the technocratic model, for it…
The investigators have since completed Phase II of the study… [with significant differing results from phase 1]. The research, published in The Journal of Psychopharmacology, is an essential first step in demonstrating the safety and feasibility of psilocybin [in phase 1 trials]. Original Article (Scitech daily):Psychedelic drug from magic mushrooms – psilocybin – can be safely…
…facing a holdup at the FDA in bringing its LSD program to more patients… didn’t dive into what issues the agency flagged before it made its decision. Not a whole lot is known about the New York biotech except that Barrow, formerly interim CEO and chief development officer, stepped into the full-time CEO role about…
The FDA’s move is the latest blow to the psychedelic industry’s attempts to use LSD and other compounds such as psilocybin for therapeutic purposes. Mind Medicine’s shares fell 10.4% to $1.46 before the bell. In November, shares of Compass Pathways (CMPS.O) fell roughly 16% due to safety concerns on its experimental drug COMP360, which uses…
An advisory committee of the World Health Organization (WHO) has concluded there is insufficient evidence to recommend a “critical review” of kratom, which potentially could have lead to international controls on the herbal supplement used by millions to treat pain and other medical conditions. “It is a great victory for kratom consumers, for science and…
Of those who used psychedelics, half said that their past use had a significant positive impact on their ability to cope with lockdowns, while 16 percent said it had a small impact, and 35 percent said it didn’t make a difference. Greater significant impacts were reported among those who used psychedelics regularly than those who…
“The Committee concluded that there is insufficient evidence to recommend a critical review of kratom.” While the decision was based on a scientific review of the risk of dependence, abuse potential and therapeutic applications of kratom, advocates also touted the fact that about 80,000 people submitted comments to the panel, sharing their perspectives and experiences…
A growing body of research shows the drug allows parts of the brain that typically don’t talk to each other to do just that — creating new pathways for thinking, learning and behaving. Unlike ketamine, however, psilocybin has been deemed dangerous by the FDA with “no medical use.” “That really stems back to the Nixon…
Recent Comments